| Dr Jose Garrido, MD | |
|
273 Highway 11 E, Bulls Gap, TN 37711-3433 | |
| (423) 393-4146 | |
| (423) 393-4377 |
| Full Name | Dr Jose Garrido |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 35 Years |
| Location | 273 Highway 11 E, Bulls Gap, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982640140 | NPI | - | NPPES |
| 3332506 | Medicaid | TN | |
| 3332507 | Medicaid | TN | |
| 010186285 | Medicaid | VA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emmaus Medical And Counseling | 1153673389 | 3 |
| Emmaus Medical And Counseling | 1153673389 | 3 |
News Archive
A new study from the University of Southern California, Keck School of Medicine, concluded that the incidence of vaping among young people is rising because of advertising for e-cigarettes using cartoon characters.
Surgeons at North Tees and Hartlepool NHS Foundation Trust are pioneering a novel technique for breast reconstruction that has the potential to make a huge difference to the lives of women affected by breast cancer.
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
NewLink Genetics Corporation announced today data from a Phase 1/2 study showing that patients with progressive advanced non-small cell lung cancer treated with its HyperAcute®-Lung cancer immunotherapy experienced favorable median survival. The data were presented at the 101st American Association for Cancer Research (AACR) Annual Meeting.
› Verified 7 days ago
| Entity Name | Southeastern Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083835441 PECOS PAC ID: 0042307852 Enrollment ID: O20071025000571 |
News Archive
A new study from the University of Southern California, Keck School of Medicine, concluded that the incidence of vaping among young people is rising because of advertising for e-cigarettes using cartoon characters.
Surgeons at North Tees and Hartlepool NHS Foundation Trust are pioneering a novel technique for breast reconstruction that has the potential to make a huge difference to the lives of women affected by breast cancer.
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
NewLink Genetics Corporation announced today data from a Phase 1/2 study showing that patients with progressive advanced non-small cell lung cancer treated with its HyperAcute®-Lung cancer immunotherapy experienced favorable median survival. The data were presented at the 101st American Association for Cancer Research (AACR) Annual Meeting.
› Verified 7 days ago
| Entity Name | Emmaus Medical And Counseling |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598256117 PECOS PAC ID: 1153673389 Enrollment ID: O20181016002174 |
News Archive
A new study from the University of Southern California, Keck School of Medicine, concluded that the incidence of vaping among young people is rising because of advertising for e-cigarettes using cartoon characters.
Surgeons at North Tees and Hartlepool NHS Foundation Trust are pioneering a novel technique for breast reconstruction that has the potential to make a huge difference to the lives of women affected by breast cancer.
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
NewLink Genetics Corporation announced today data from a Phase 1/2 study showing that patients with progressive advanced non-small cell lung cancer treated with its HyperAcute®-Lung cancer immunotherapy experienced favorable median survival. The data were presented at the 101st American Association for Cancer Research (AACR) Annual Meeting.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jose Garrido, MD 273 Highway 11 E, Bulls Gap, TN 37711-3433 Ph: (423) 393-4146 | Dr Jose Garrido, MD 273 Highway 11 E, Bulls Gap, TN 37711-3433 Ph: (423) 393-4146 |
News Archive
A new study from the University of Southern California, Keck School of Medicine, concluded that the incidence of vaping among young people is rising because of advertising for e-cigarettes using cartoon characters.
Surgeons at North Tees and Hartlepool NHS Foundation Trust are pioneering a novel technique for breast reconstruction that has the potential to make a huge difference to the lives of women affected by breast cancer.
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
NewLink Genetics Corporation announced today data from a Phase 1/2 study showing that patients with progressive advanced non-small cell lung cancer treated with its HyperAcute®-Lung cancer immunotherapy experienced favorable median survival. The data were presented at the 101st American Association for Cancer Research (AACR) Annual Meeting.
› Verified 7 days ago
Mark R Doman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 260 Highway 11 E, Bulls Gap, TN 37711 Phone: 423-235-4191 Fax: 423-235-7092 |